These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9054933)
61. Emerging and potential use of CRISPR in human liver disease. Adlat S; Vázquez Salgado AM; Lee M; Yin D; Wangensteen KJ Hepatology; 2023 Aug; ():. PubMed ID: 37607734 [TBL] [Abstract][Full Text] [Related]
62. Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study. Dawood RM; Abd El Meguid M; Elrobe W; Salum GM; Zayed N; Mousa S; Medhat E Asian Pac J Cancer Prev; 2021 Sep; 22(9):2837-2845. PubMed ID: 34582652 [TBL] [Abstract][Full Text] [Related]
66. The significance of haemochromatosis gene mutations in the general population: implications for screening. Burt MJ; George PM; Upton JD; Collett JA; Frampton CM; Chapman TM; Walmsley TA; Chapman BA Gut; 1998 Dec; 43(6):830-6. PubMed ID: 9824612 [TBL] [Abstract][Full Text] [Related]
67. A PCR-SSP method for detecting the Cys282Tyr mutation in the HFE gene associated with hereditary haemochromatosis. Smillie D Mol Pathol; 1997 Oct; 50(5):275-6. PubMed ID: 9497921 [TBL] [Abstract][Full Text] [Related]
68. Targeted disruption of the HFE gene. Beutler E Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2033-4. PubMed ID: 9482831 [No Abstract] [Full Text] [Related]
69. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Parkkila S; Waheed A; Britton RS; Bacon BR; Zhou XY; Tomatsu S; Fleming RE; Sly WS Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13198-202. PubMed ID: 9371823 [TBL] [Abstract][Full Text] [Related]
70. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Waheed A; Parkkila S; Zhou XY; Tomatsu S; Tsuchihashi Z; Feder JN; Schatzman RC; Britton RS; Bacon BR; Sly WS Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12384-9. PubMed ID: 9356458 [TBL] [Abstract][Full Text] [Related]
71. [Genetic background and DNA diagnostics of hemochromatosis]. Heliö T; Färkkilä M; Halme L; Karlsson M; Palotie A; Kontula K Duodecim; 1998; 114(14):1404-9. PubMed ID: 11552248 [No Abstract] [Full Text] [Related]
72. Putting a hold on "HLA-H'. The WHO Nomenclature Committee for Factors of the HLA System. Bodmer JG; Parham P; Albert ED; Marsh SG Nat Genet; 1997 Mar; 15(3):234-5. PubMed ID: 9054933 [No Abstract] [Full Text] [Related]
73. Putting a hold on 'HLA-H'. Mercier B; Mura C; Ferec C Nat Genet; 1997 Mar; 15(3):234. PubMed ID: 9054932 [No Abstract] [Full Text] [Related]
74. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda. Santos M; Clevers HC; Marx JJ N Engl J Med; 1997 May; 336(18):1327-8. PubMed ID: 9132598 [No Abstract] [Full Text] [Related]
75. Mutation analysis of the HLA-H gene in French hemochromatosis patients, and genetic counseling in families. Mercier G; Burckel A; Bathelier C; Boillat E; Lucotte G Genet Couns; 1998; 9(3):181-6. PubMed ID: 9777338 [TBL] [Abstract][Full Text] [Related]
76. Celtic origin of the C282Y mutation of hemochromatosis. Lucotte G Blood Cells Mol Dis; 1998 Dec; 24(4):433-8. PubMed ID: 9851897 [TBL] [Abstract][Full Text] [Related]